
Bristol's Astral Systems secures €26 million Series A to support medical isotope commercialisation - EU-Startups
Astral Systems is a British DeepTech firm that specializes in pioneering multi-state fusion technology. The company aims to produce critical medical isotopes for diagnosis, treatment, and research, addressing the fragile supply chain and potential global shortages in this area.
Bristol's Astral Systems secures €26 million Series A to support medical isotope commercialisation EU-Startups

| Jul 13, 2026 | HBD | $130.0M | Grant | United Kingdom |
| Jul 13, 2026 | Reformed | $22.0M | Series A | United Kingdom |
| Jul 13, 2026 | Henry Boot | $130.0M | Grant | United Kingdom |
| Jul 10, 2026 | Luffy AI | $10K | Series A | United Kingdom |